Apostolova P, Kreutmair S, Toffalori C, Punta M, et al. Phase II trial of hypomethylating agent combined with nivolumab for acute myeloid leukaemia relapse after allogeneic haematopoietic cell transplantation-Immune signature correlates with response. Br J Haematol 2023;203:264-281.
PMID: 37539479